🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2031

Annual patent cliff calendar for 2031 — US pharmaceutical patents by expiration date.

Patents
874

Quick answer

874 indexed pharmaceutical patents have expiration dates in 2031. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7960384

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7960383

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7960348

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7959934

    Method for rapid generation of mature dendritic cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7959929

    Materials and methods for respiratory disease control in canines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7959923

    Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA

    The Regents of the University of California · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7959925

    Trimeric OX40-immunoglobulin fusion protein and methods of use

    Providence Health System · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7960356

    Oligodeoxynucleotide and its use to induce an immune response

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7960369

    Receptor function regulator

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7960372

    Bivalent Smac mimetics and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7960133

    Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase

    The Board of Regents of the University of Texas System · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7960398

    Regulation of TNF-alpha

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7960606

    Mouse model of chronic heart failure and coronary atherosclerosis regression

    The Regents of the University of California · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7960586

    Purification of armodafinil

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7960605

    Methods for testing for caloric restriction (CR) mimetics

    BioMarker Pharmaceuticals, Inc. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7960416

    Stable emulsion composition

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7964748

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7964712

    Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains

    The Regents of the University of California · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7964702

    Phalloidin derivatives and methods for their synthesis

    The Regents of the University of California · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7964624

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7964615

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor

    Almirall, S.A. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7964591

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7964561

    Protein formulations for use at elevated temperatures

    Advanced Technologies and Regenerative Medicine, LLC · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7964576

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7964559

    MVL, an antiviral protein from a cyanobacterium

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7964217

    Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor

    Nektar Therapeutics · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7964187

    Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

    ONCOLYTICS BIOTECH INC. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7964186

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7964646

    3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

    Pharmacopeia Drug Discovery, Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7964612

    Therapeutic pyrazolyl thienopyridines

    Graceway Pharmaceuticals. LLC · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7964359

    Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance

    Acumen Pharmaceuticals, Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7964573

    Regulating expression of transient receptor potential channel genes

    The Regents of the University of California · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7964730

    Amino-substituted ethylamino β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7964188

    Use of placental alkaline phosphatase to promote skin cell proliferation

    Essential Skincare, LLC · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7964377

    Nucleic acid molecule encoding a fusion polypeptide capable of binding VEGF

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7964590

    Cyclopamine lactam analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7964710

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7968545

    Compositions useful as inhibitors of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7968117

    Externally triggered microcapsules

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7968615

    Polymerizable monomer, polymerizable composition and dental material

    Kuraray Medical Inc. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7968298

    Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7968080

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7968716

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7968115

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7968511

    Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7968664

    Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7968559

    Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7968726

    Methods of preparing imidazole-based bicyclic compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2031?

874 published patents in our USPTO index have expiration dates falling in calendar year 2031.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.